[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7528 Introduced in House (IH)]

<DOC>






119th CONGRESS
  2d Session
                                H. R. 7528

 To amend section 503B of the Federal Food, Drug, and Cosmetic Act to 
    enhance the ability of outsourcing facilities to mitigate drug 
  shortages by allowing a short-term period to continue supplying the 
                  market after a drug is in shortage.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 12, 2026

Mr. Carter of Georgia introduced the following bill; which was referred 
                to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To amend section 503B of the Federal Food, Drug, and Cosmetic Act to 
    enhance the ability of outsourcing facilities to mitigate drug 
  shortages by allowing a short-term period to continue supplying the 
                  market after a drug is in shortage.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Growing America's Pharmaceutical 
Supply Act'' or the ``GAP Supply Act''.

SEC. 2. PROVIDING FOR A TAIL PERIOD FOR OUTSOURCING FACILITIES TO 
              COMPOUND AND DISTRIBUTE DRUGS IN SHORTAGE.

    Section 503B of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
353b) is amended--
            (1) in subsection (a)(2)(A)(ii), by striking ``at the 
        time'' and inserting ``within 180 calendar days''; and
            (2) in subsection (d)(2)(A), by striking ``at the time'' 
        and inserting ``within 180 calendar days''.
                                 <all>